role of 5-hydroxytryptamine 1a receptors in 6-hydroxydopmaine-induced catalepsy-like immobilization in rats: a therapeutic approach for treating catalepsy of parkinson’s disease

Authors

siamak reyhani-rad science and research branch, islamic azad university, tehran, iran.

alireza nayebi department of pharmacology and toxicology, faculty of pharmacy, tabriz university of medical sciences. drug applied research center, tabriz university of medical sciences.

javad mahmoudi neurosciences research center (nsrc), tabriz university of medical sciences, tabriz iran.

morteza samini science and research branch, islamic azad university, tehran, iran.

abstract

we have shown that buspirone, a partial agonist of 5-hydroxytryptamine 1a (5-ht1a) receptors, improves motor dysfunctions induced by 6-hydroxydopamine (6-ohda) and haloperidol in rats. the present work extends these findings by investigating the role of 5-ht1a receptors on catalepsy-like immobilization in rats, a model of parkinson’s disease. catalepsy was induced by unilateral infusion of 6-oh-dopamine (8 µg/2µl/rat) into the central region of the substantia nigra, compact part (snc) and assayed by bar-test method 5, 60, 120 and 180 min after the drugs administration. the involvement of 5-ht1a receptors in 6-ohda-induced catalepsy was studied through intraperitoneal (0.25, 0.5 and 1mg/kg ip) and intrasubstantia nigra, compact part (10 µg/rat, intra-snc) injection of 8-hydroxy-2-[di-n-propylamino] tetralin (8-ohdpat) as well as administration of 1-(2-methoxyphenyl)-4-[4-(2-pthalimmido) butyl] piperazine hydrobromide (0.1, 0.5 and 1 mg/kg, nan-190, ip). nan-190 (1 mg/kg, ip) and 8-ohdpat (1 mg/kg, ip and 10 µg/rat, intra-snc) increased and decreased 6-ohda-induced catalepsy respectively. in normal (non 6-ohda-lesioned) rats, nan-190 (1 mg/kg, ip) increased the elapsed time in bar-test while 8-ohdpat did not produce any significant effect. the anticataleptic effect of 8-ohdpat (1 mg/kg, ip) was reversed markedly by co-injection with nan-190 (1 mg/kg, ip). these findings suggest that 5-ht1a receptors are involved in 6-ohda-induced catalepsy-like immobilization.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson’s Disease

We have shown that buspirone, a partial agonist of 5-hydroxytryptamine 1A (5-HT1A) receptors, improves motor dysfunctions induced by 6-hydroxydopamine (6-OHDA) and haloperidol in rats. The present work extends these findings by investigating the role of 5-HT1A receptors on catalepsy-like immobilization in rats, a model of Parkinson’s disease. Catalepsy was induced by unilateral infusion of 6-OH...

full text

Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson’s Disease

We have shown that buspirone, a partial agonist of 5-hydroxytryptamine 1A (5-HT1A) receptors, improves motor dysfunctions induced by 6-hydroxydopamine (6-OHDA) and haloperidol in rats. The present work extends these findings by investigating the role of 5-HT1A receptors on catalepsy-like immobilization in rats, a model of Parkinson’s disease. Catalepsy was induced by unilateral infusion of 6-OH...

full text

Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson’s Disease

We have shown that buspirone, a partial agonist of 5-hydroxytryptamine 1A (5-HT1A) receptors, improves motor dysfunctions induced by 6-hydroxydopamine (6-OHDA) and haloperidol in rats. The present work extends these findings by investigating the role of 5-HT1A receptors on catalepsy-like immobilization in rats, a model of Parkinson's disease. Catalepsy was induced by unilateral infusion of 6-OH...

full text

Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats.

Receptors for 5-HT(1A) are widely distributed throughout the basal ganglia, and their activation results in an inhibition of dopamine (DA) release. This study aimed to investigate the effect of buspirone, as a partial agonist of 5-HT(1A) receptors, on 6-hydroxydopamine (6-OHDA)-induced catalepsy in male Wistar rats. Catalepsy was induced by unilateral infusion of 6-OH-DA (6 microg/2 microl/rat)...

full text

Effect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats

Objective(s): Neuroinflammation and oxidative stress play a key role in pathogenesis of Parkinson’s disease (PD). In the present study we investigated the effect of reactive oxygen species (ROS) scavenger WR-1065 on catalepsy and cerebrospinal fluid (CSF) level of interleukin 6(IL-6) and striatum superoxide dismutase (SOD) activity  in 6-hydroxydopamine (6-OHDA) induced experimental model of PD...

full text

Dose-Dependent Effect of Flouxetine on 6-OHDA-Induced Catalepsy in Male Rats: A Possible Involvement of 5-HT1A Receptors.

PURPOSE Progressive loss of dopaminergic neurons of the substantia nigra pars compacta (SNc) in Parkinson's disease (PD) leads to impairment of motor skills. Several evidences show that the role of serotonergic system in regulation of normal movement is pivotal and mediates via 5-HT1A receptors. Our previous study has shown that fluoxetine in acute injections able to attenuate catalepsy in 6-hy...

full text

My Resources

Save resource for easier access later


Journal title:
the iranian journal of pharmaceutical research

جلد ۱۱، شماره ۴، صفحات ۱۱۷۵-۱۱۸۱

Keywords
[ 5 , ' h t 1 a ' , 6 , ' h y d r o x y d o p a m i n e ' , 8 , ' o h d p a t ' , ' n a n ' , 1 9 0 , ' c a t a l e p s y ' ]

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023